GB9819914D0 - Genetic suppression therapy - Google Patents

Genetic suppression therapy

Info

Publication number
GB9819914D0
GB9819914D0 GBGB9819914.4A GB9819914A GB9819914D0 GB 9819914 D0 GB9819914 D0 GB 9819914D0 GB 9819914 A GB9819914 A GB 9819914A GB 9819914 D0 GB9819914 D0 GB 9819914D0
Authority
GB
United Kingdom
Prior art keywords
suppression therapy
genetic suppression
genetic
therapy
suppression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9819914.4A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Europaisches Laboratorium fuer Molekularbiologie EMBL
Original Assignee
Europaisches Laboratorium fuer Molekularbiologie EMBL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Europaisches Laboratorium fuer Molekularbiologie EMBL filed Critical Europaisches Laboratorium fuer Molekularbiologie EMBL
Priority to GBGB9819914.4A priority Critical patent/GB9819914D0/en
Publication of GB9819914D0 publication Critical patent/GB9819914D0/en
Priority to PCT/IB1999/001548 priority patent/WO2000015843A1/en
Priority to AU55283/99A priority patent/AU5528399A/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • C07K14/43577—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
    • C07K14/43581—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies from Drosophila
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/033—Rearing or breeding invertebrates; New breeds of invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Insects & Arthropods (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Animal Husbandry (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB9819914.4A 1998-09-11 1998-09-11 Genetic suppression therapy Ceased GB9819914D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB9819914.4A GB9819914D0 (en) 1998-09-11 1998-09-11 Genetic suppression therapy
PCT/IB1999/001548 WO2000015843A1 (en) 1998-09-11 1999-09-07 Genetic suppression therapy
AU55283/99A AU5528399A (en) 1998-09-11 1999-09-07 Genetic suppression therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9819914.4A GB9819914D0 (en) 1998-09-11 1998-09-11 Genetic suppression therapy

Publications (1)

Publication Number Publication Date
GB9819914D0 true GB9819914D0 (en) 1998-11-04

Family

ID=10838779

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9819914.4A Ceased GB9819914D0 (en) 1998-09-11 1998-09-11 Genetic suppression therapy

Country Status (3)

Country Link
AU (1) AU5528399A (en)
GB (1) GB9819914D0 (en)
WO (1) WO2000015843A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1860199B1 (en) 2001-01-12 2014-03-05 Exelixis, Inc. Modulating insulin receptor signaling

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0942977A2 (en) * 1996-11-15 1999-09-22 Cedars-Sinai Medical Center Nucleic acid encoding schwannomin-binding-proteins and products related thereto
US5780236A (en) * 1996-11-18 1998-07-14 Wisconsin Alumni Research Foundation Method for identifying mutants and molecules

Also Published As

Publication number Publication date
AU5528399A (en) 2000-04-03
WO2000015843A1 (en) 2000-03-23

Similar Documents

Publication Publication Date Title
EG24678A (en) Combination therapy
GB9820113D0 (en) Therapeutic agents
GB9816263D0 (en) Therapeutic agents
GB9806102D0 (en) Therapeutic agents
GB9804885D0 (en) Therapeutic combination
IL127306A0 (en) Combination therapy
GB9808663D0 (en) Therapeutic agents
GB9812038D0 (en) Therapeutic compound
GB9930570D0 (en) Therapy
GB9801234D0 (en) Therapeutic agents
GB9813576D0 (en) Therapeutic agents
GB9813006D0 (en) Therapeutic agents
GB9700939D0 (en) Therapy
GB9801210D0 (en) Therapeutic agents
GB9907243D0 (en) Therapy
GB9816556D0 (en) Therapy
AP9901436A0 (en) Therapeutic agents
GB9801397D0 (en) Therapeutic agents
GB9801202D0 (en) Therapeutic agents
GB9819484D0 (en) Therapeutic agents
GB9810092D0 (en) Therapeutic agents
GB9811879D0 (en) Therapeutic agents
GB9815317D0 (en) Therapeutic agents
GB9819914D0 (en) Genetic suppression therapy
GB9817838D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)